Ignite Creation Date:
2024-07-17 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06475495
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-06-13
Brief Title:
Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Organization Data
Organization:
Charite University Berlin Germany
Class:
OTHER
Study ID:
CCM-RNT-202401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Charite University Berlin Germany
Lead Sponsor Class:
OTHER
Responsible Party:
David Simon
Responsible Party Title:
PD Dr med David Simon
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Charite University Berlin Germany
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Kyverna Therapeutics | INDUSTRY |